Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis

Human Immunology

Volumn 76, Issue 8, 2015, Pages 571-577

  Margolis, David J ^a,b   Mitra, Nandita ^a,b   Kim, Brian ^c   Gupta, Jayanta ^d   Hoffstad, Ole J ^a,b   Papadopoulos, Maryte ^a,b   Wubbenhorst, Bradley ^a,d   Nathanson, Katherine L ^a,b,f   Duke, Jamie L ^e   Monos, Dimitri S ^a,b,e   Kamoun, Malek ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atopic dermatitis; HLA alleles

Indexed keywords

HLA DRB1 ANTIGEN;

ALLELE; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; DERMATITIS, ATOPIC; EXOME; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; INFANT; MALE; NEWBORN; ODDS RATIO; PRESCHOOL CHILD; REGISTER;

ALLELES; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; DERMATITIS, ATOPIC; EXOME; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HLA-DRB1 CHAINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; ODDS RATIO; REGISTRIES;

EID: 84953363796     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.08.003     Document Type: Article

References (50)

1. Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006, 61(8):969-987.
2. Charman C.R., Williams H.C. Epidemiology. Atopic Dermatitis 2002, 21-42. Marcel Dekker, Inc., New York. first Ed. T. Bieber, D.Y.M. Leung (Eds.).
3. Hanifin J.M., Reed M.L. A population-based survey of eczema prevalence in the United States. Dermatitis 2007, 82(2):82-91. Eczema Prevalence and Impact Working Group.
4. Silverberg J.I., Hanifin J.M. Adult eczema prevalence and associations with asthma and other variables: a US population-based study. J. Allergy Clin. Immunol. 2013, 132(5):1132-1138.
5. Eichenfield L.F., Tom W.L., Chamlin S.L., Feldman S.R., Hanifin J.M., Simpson E.L., et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. [Review]. J. Am. Acad. Dermatol. 2014, 70(2):338-351.
6. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
7. Hoare C., Li Wan Po A., Williams H. Systemic review of treatments for atopic eczema. Health Technol. Assess. 2002, 4:1-191.
8. Silverberg J.I., Simpson E.L. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr. Allergy Immunol. 2013, 24(5):476-486.
9. Margolis J.S., Abuabrar K., Bilker W., Hoffstad O., Margolis D.J. Persistance of mild of mild to moderate atopic dermatitis. JAMA Dermatol. 2014, 150(6):593-600.
10. Dhinga N., Gulati N., Guttman-Yassky E. Mechanisms of contact sensitization offer insights into roll of barrier defects vs intrinsic immune abnormalities as drivers of atopic dermatitis. J. Invest. Dermatol. 2013, 133:2311-2314.
11. Newell L., Polak M.E., Perera J., Owen C., Boyd P., Pickard C., et al. Sensitization via healthy skin programs Th2 responses in indivduals with atopic dermatitis. J. Invest. Dermatol. 2013, 133:2372-2380.
12. Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis - Part I: clinical and pathologic concepts. [Review]. J. Allergy Clin. Immunol. 2011, 127(5):1110-1118.
13. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006, 38(4):441-446.
14. Margolis D.J., Apter A.J., Gupta J., Hoffstad O., Papadopoulos M., Campbell L.E., et al. The persistence of atopic dermatitis and Filaggrin mutations in a US longitudinal cohort. J. Allergy Clin. Immunol. 2012, 130(4):912-917.
15. Winge M.C., Bilcha K.D., Lieden A., Shibeshi D., Sandilands A., Wahlgren C.F., et al. Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis. Br. J. Dermatol. 2011, 165(5):1074-1080.
16. Margolis D.J., Gupta J., Apter A., Hoffstad O., Papdopoulos M., Rebbeck T.R., et al. Exome sequencing of Filaggrin and related genes in African-American children with atopic dermatitis. J. Invest. Dermatol. 2014, 134(8):2272-2274.
17. Thaswer-Esmail F., Jakasa I., Todd G., Wen Y., Brown S.J., Krobach K., et al. South African amaXhosa patient with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin. J. Allergy Clin. Immunol. 2014, 133(1):280-282.
18. Polican I., Becker L., Stein S.L., Smith M.S., Aller A.S. Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr. Dermatol. 2014, 31(4):489-492.
19. Margolis D.J., Gupta J., Apter A.J., Ganguly T., Hoffstad O., Papadopoulos M., et al. Filaggrin-2 variation is associated wtih more persistent atopic dermatitis in Arican Americans. J. Allergy Clin. Immunol. 2014, 133(3):784-789.
20. Barnes K.C. An update on the genetics of atopic dermatitis: scratching the surface in 2009. [Review] [219 refs]. J. Allergy Clin. Immunol. 2010, 125(1):16-29.
21. Margolis D.J., Kim B., Apter A.J., Gupta J., Hoffstad O., Papadopoulos M., et al. Thymic stromal lymphopoietin variation, filaggrin loss-of-function, and persistence of atopic dermatitis. JAMA Dermatol. 2013, 150(3):254-259.
22. Noti M., Wojno E.D., Kim B.S., Siracusa M.C., Giacomin P.R., Nair M.G., et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat. Med. 2013, 19(8):1005-1013.
23. Rothenberg M.E., Spergel J.M., Sherrill J.D., Annaiah K., Martin L.J., Cianferoni A., et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat. Genet. 2010, 42(4):289-291.
24. Gauvreau G.M., O'Bryne P.M., Boulet L.P., Wang Y., Cockcroft D., Bigler J., et al. Effects of anti-TSLP antibody on allergin-induced asthmatic reponses. New Engl. J. Med. 2014, 370:2102-2110.
25. Trowsdale J., Knight J.C. Major histocompatibility compex genomics and human disease. Annu. Rev. Genomics Hum. Genet. 2013, 14:301-323.
26. Krawczyk M., Reith W. Regulation of MHC class II expression, a unique regulatory system identified by the study of primary immunodeficiency disease. Tissue Antigens 2006, 67:183-197.
27. Kim B.S., Wang K., Siracusa M.C., Saenz S.A., BrestoffJ.R., Monticelli L.A., et al. Basophils promote innnate lymphoid cell responses in inflammed skin. J. Immunol. 2014, 193:3717-3725.
28. + Th2 cell responses. J. Immunol. 2014, 192(5):2442-2448.
29. Ellinghaus D., Baurecht H., Esparza-Gordillo J., Rodriguez E., Matanovic A., Marenholz I., et al. High-density genotyping study indentifies four new susceptibility loci for atopic dermatitis. Nat. Genet. 2013, 45:808-812.
30. Hirota T., Takahashi A., Kubo M., Tsunoda T., Tomita K., Sakashita M., et al. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat. Genet. 2012, 44(11):1222-1226.
31. Paternoster L., Standl M., Chen C.M., Ramasamy A., Bonnelykke K., Duijts L., et al. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat. Genet. 2012, 44(2):187-192.
32. Weidinger S., Willis-Owen S.A., Kamatani Y., Baurecht H., Morar N., Liang L., et al. A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum. Mol. Genet. 2013, 22(23):4841-4856.
33. Esparza-Gordillo J., Weidinger S., Folster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat. Genet. 2009, 41(5):596-601.
34. Sun L.D., Xiao F.L., Li Y., Zhou W.M., Tang H.Y., Tang X.F., et al. Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat. Genet. 2011, 43(7):690-694.
35. Bussman C., Weidinger S., Novak N. Genetics of atopic dermatitis. JDDG J. German Soc. Dermatol. 2011, 9:670-679.
36. Kendall E., Sargent C.A., Campbel R.D. Human major histocompatibility complex contains a new cluster of genes between HLA-D and complement C4 loci. Nucleic Acids Res. 1990, 18(24):7251-7257.
37. Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K., et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J. Am. Acad. Dermatol. 2014, 71(1):116-132.
38. Sidbury R., Tom W.L., Bergman J.N., Cooper K.D., Silverman R.A., Berger T.G., et al. Guidelines of care for the management of atopic dermatitis: Section 4: prevention of disease flares and use of adjunctive therapies and approaches. J. Am. Acad. Dermatol. 2014, 71:1218-1233.
39. Kanterakis S., Magira E., Rosenman K.D., Rossman M., Talsznia K., Monos D.S. SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software. Hum. Immunol. 2008, 69:522-525.
40. Maiers M., Gragert L., Klitz W. High resolution HLA alleles and haplotypes in the US population. Hum. Immunol. 2007, 68:779-788.
41. Major E., Rigo K., Hague T., Berces A., Juhos S. HLA typing from 1000 genomes whole genome and whole exome Illumina data. PLoS One 2013, 8(11):e78410.
42. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368:215-221.
43. Reche P.A., Reinherz E.L. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J. Mol. Biol. 2003, 331:623-641.
44. Androulakis I.P., Nayak N.N., Ierapetritou M.G., Mono D.S., Floudas C.A. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions. Proteins 1997, 29:87-102.
45. Thomson G., Marthandan N., Hollenbach J.A., Mack S.J., Erlich H.A., Single R.M., et al. Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis. Pac. Symp. Biocomput. 2010, 359-370.
46. Aron Y., Desmazes-Dufeu N., Matran R., Polla B.S., Dusser D., Lockhart A., et al. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7. Clin. Exp. Allergy 1996, 26:821-828.
47. Howell W.M., Standring P., Warner J.A., Warner J.O. HLA class II genotype, HLA-DR B cell surface expression and allergan specific IgE production in atopic and non-atopic members of asthmatic family pedigrees. Clin. Exp. Allergy 1999, 29(Suppl. 4):35-38.
48. Saeki H., Kuwata S., Nakagawa H., Etoh T., Yanagisawa M., Miyamoto M., et al. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J. Allergy Clin. Immunol. 1995, 96:1061-1068.
49. Park H., Ahn K., Park M.H., Lee S.I. The HLA-DRB1 polymorphism is associated with atopic dermatitis, but not egg allergy in Korean children. Allergy Asthma Immunol. Res. 2012, 4(3):143-149.
50. Madore A.M., Vaillancourt V.T., Asi Y., Alizadehfar R., Ben-Shoshan M., Michel D.L., et al. HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy. Eur. J. Hum. Genet. 2013, 21:1181-1184.